- Home
- HCAI vs LSTA Comparison
HCAI vs LSTA Comparison
Compare HCAI & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HCAI | LSTA |
|---|---|---|
| Founded | 2004 | 1980 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Miscellaneous manufacturing industries | Misc Health and Biotechnology Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.3M | 20.9M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | HCAI | LSTA |
|---|---|---|
| Price | $0.34 | $2.07 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $23.50 |
| AVG Volume (30 Days) | ★ 70.4K | 23.9K |
| Earning Date | 12-19-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.00 | N/A |
| Revenue | ★ $19,176,987.00 | $1,070,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $93.94 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.30 | $1.81 |
| 52 Week High | $10.97 | $4.20 |
Technical Indicators
Market Signals| Indicator | HCAI | LSTA |
|---|---|---|
| Relative Strength Index (RSI) | 33.92 | 43.94 |
| Support Level | $0.34 | $1.97 |
| Resistance Level | $0.44 | $2.15 |
| Average True Range (ATR) | 0.04 | 0.12 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 28.05 | 46.87 |
Price Performance
Historical ComparisonAbout HCAI Huachen AI Parking Management Technology Holding Co. Ltd. Ordinary Shares
Huachen AI Parking Management Technology Holding Co Ltd is a comprehensive smart parking solutions and equipment structural parts provider. The company manufactures and offer various cubic parking garage products by employing various working principles, such as lifting and shifting, convenient lifting, vertical circulation, vertical lifting, plane moving, alley stacking, multi-layer cycle, horizontal cycle, and car lift.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.